Concurrent cisplatin and radiation versus cetuximab and radiation for locally advanced head-and-neck cancer

International Journal of Radiation Oncology Biology Physics

Volumn 81, Issue 4, 2011, Pages 915-922

  Koutcher, Lawrence ^a   Sherman, Eric ^a   Fury, Matthew ^a   Wolden, Suzanne ^a   Zhang, Zhigang ^a   Mo, Qianxing ^a   Stewart, Laschelle ^a   Schupak, Karen ^a   Gelblum, Daphna ^a   Wong, Richard ^a   Kraus, Dennis ^a   Shah, Jatin ^a   Zelefsky, Michael ^a   Pfister, David ^a   Lee, Nancy ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Cetuximab; Cisplatin; Late effects; Locally advanced head and neck cancer; Overall survival

Indexed keywords

CETUXIMAB; CIS-PLATIN; HEAD-AND-NECK CANCER; LATE EFFECTS; OVERALL SURVIVAL;

DISEASES; MULTIVARIANT ANALYSIS; PLATINUM COMPOUNDS; RISK ANALYSIS; RISK ASSESSMENT;

RADIOTHERAPY;

CETUXIMAB; CISPLATIN;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CONTROLLED STUDY; CREATININE CLEARANCE; FAILURE FREE SURVIVAL; FEEDING APPARATUS; FEMALE; FOLLOW UP; HEAD AND NECK CANCER; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; SURVIVAL; TREATMENT FAILURE;

AGED; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; CISPLATIN; CREATININE; DISEASE-FREE SURVIVAL; DRUG SUBSTITUTION; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; HYPOPHARYNGEAL NEOPLASMS; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; OROPHARYNGEAL NEOPLASMS; PROPORTIONAL HAZARDS MODELS; RADIOTHERAPY, INTENSITY-MODULATED; RETROSPECTIVE STUDIES;

EID: 80255134559     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2010.07.008     Document Type: Article

References (31)

1. S. Kramer, R.D. Gelber, and J.B. Snow Combined radiation therapy and surgery in the management of advanced head and neck cancer: Final report of study 73-03 of the Radiation Therapy Oncology Group Head Neck Surg 10 1987 19 30 (Pubitemid 19098977)
2. J.T. Parsons, W.M. Mendenhall, and S.P. Stringer Squamous cell carcinoma of the oropharynx: surgery, radiation therapy, or both Cancer 94 2002 2967 2980 (Pubitemid 34547697)
3. The Department of Veteran Affairs Laryngeal Cancer Study Group Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer N Engl J Med 324 1991 1685 1690
4. J.L. Lefebvre, D. Chevalier, and B. Luboinski Larynx preservation in pyriform sinus cancer: Preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group J Natl Cancer Inst 88 1996 890 899 (Pubitemid 26230640)
5. A.S. Garden, J.A. Asper, and W.H. Morrison Is concurrent chemoradiation the treatment of choice for all patients with Stage III or IV head and neck carcinoma? Cancer 100 2004 1171 1178 (Pubitemid 38325944)
6. D.M. Brizel, M.E. Albers, and S.R. Fisher Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer N Engl J Med 338 1998 1798 1804 (Pubitemid 28277960)
7. D.J. Adelstein, Y. Li, and G.L. Adams An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer J Clin Oncol 21 2003 92 98
8. A.A. Forastiere, H. Goepfert, and M. Maor Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer N Eng J Med 349 2003 2091 2098 (Pubitemid 37464533)
9. F. Denis, P. Garaud, and E. Bardet Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced stage oropharynx carcinoma J Clin Oncol 22 2004 69 76 (Pubitemid 41095116)
10. J.P. Pignon, A.L. Maître, and E. Maillard Meta-analyses of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patients Radiother Oncol 92 2009 4 14
11. J. Bernier, and D. Schneider Cetuximab combined with radiotherapy: An alternative to chemoradiotherapy for patients with locally advanced squamous cell carcinomas of the head and neck? Eur J Cancer 43 2007 35 45 (Pubitemid 46054482)
12. N.I. Goldstein, M. Prewett, and K. Zuklys Biological efficacy of a chimeric antibody to the epidermal growth factor receptor in a human tumor xenograft model Clin Cancer Res 1 1995 1311 1318
13. J.A. Bonner, P.M. Harari, and J. Giralt Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck N Engl J Med 354 2006 567 578 (Pubitemid 43209104)
14. D. Curran, J. Giralt, and P.M. Harari Quality of life in head and neck cancer patients after treatment with high-dose radiotherapy alone or in combination with cetuximab J Clin Oncol 25 2007 2191 2197 (Pubitemid 46954642)
15. D.G. Pfister, B. Su, and D. Kraus Concurrent cetuximab, cisplatin, and concomitant boost radiotherapy for locoregionally advanced, squamous cell head and neck cancer: A pilot phase II study of a new combined-modality regimen J Clin Oncol 24 2006 1072 1078 (Pubitemid 46638804)
16. J.J. Caudell, S.M. Sawrie, and S.A. Spencer Locoregionally advanced head and neck cancer treated with primary radiotherapy: A comparison of the addition of cetuximab or chemotherapy and the impact of protocol treatment Int J Radiat Oncol Biol Phys 71 2008 676 681
17. E.L. Kaplan, and P. Meier Non parametric estimation from incomplete observations J Am Stat Assoc 53 1958 457 481
18. R.J. Gray A class of K-sample tests for comparing the cumulative incidence of a competing risk Ann Stat 16 1988 1141 1154
19. J.P. Fine, and R.J. Gray A proportional hazards model for the subdistribution of a competing risk J Am Stat Assoc 94 1999 496 509
20. P.R. Rosenbaum, and D.B. Rubin The central role of the propensity score in observational studies for causal effects Biometrika 70 1983 41 55
21. Koutcher LD, Wolden S, Lee N. Severe radiation dermatitis in patients with locally advanced head and neck cancer treated with concurrent radiation and cetuximab. Am J Clin Oncol. In press.
22. C. Giro, B. Berger, and E. Bölke High rate of severe radiation dermatitis during radiation therapy with concurrent cetuximab in head and neck cancer: Results of a survey in EORTC institutes Radiother Oncol 90 2009 166 171
23. J. Lefebvre, Y. Pointreau, and F. Rolland Sequential chemoradiotherapy (SCRT) for larynx preservation (LP): Preliminary results of the randomized phase II TREMPLIN study [Abstract] Proc Am Soc Clin Oncol 27 Suppl. 2009 15s
24. S. Firat, R.W. Byhardt, and E. Gore Comorbidity and Karnofsky Performance are independent prognostic factors in stage III non-small-cell lung cancer: An institutional analysis of patients treated on four RTOG studies Int J Radiat Oncol Biol Phys 54 2002 357 364 (Pubitemid 35286798)
25. S.F. Hall, P.A. Groome, and D. Rothwell The impact of comorbidity on survival of patients with squamous cell carcinoma of the head and neck Head Neck 22 1999 317 322
26. G.O. Schoenfeld, R.J. Amdur, and C.G. Morris Patterns of failure and toxicity after intensity-modulated radiotherapy for head and neck cancer Int J Radiat Oncol Biol Phys 71 2008 377 385
27. S. Rothschild, G. Studer, and B. Seifert PET/CT with intensity-modulated radiotherapy (IMRT) improves treatment outcome of locally advanced pharyngeal carcinoma: A matched-pair analysis Radiat Oncol 2 2007 22
28. F.F. De Arruda, D.R. Puri, and J. Zhung Intensity-modulated radiation therapy for the treatment of oropharyngeal carcinoma: The Memorial Sloan-Kettering Cancer Center experience Int J Radiat Oncol Biol Phys 64 2006 363 373 (Pubitemid 43083420)
29. 18F] fluorodeoxyglucose positron emission tomography and computed tomography assessment of radiation response of radiation response in head and neck cancer J Clin Oncol 27 2009 2509 2515
30. C. Fakhry, W.H. Westra, and S. Li Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial J Natl Cancer Inst 100 2008 261 269 (Pubitemid 351480538)
31. M.L. Gillison, J. Harris, and W. Westra Survival outcomes by tumor human papillomavirus (HPV) in stage III-IV oropharyngeal cancer (OPC) in RTOG 0129 [Abstract] Proc Am Soc Clin Oncol 27 Suppl. 2009 15s